TGFB1 and fatty liver disease: The first mechanism involved is the promotion of lipid metabolism by activation of the AMPK pathway, which in turn improves hepatic steatosis; the other is the downregulation of TGF‐β signaling, which protects from fibrogenesis (Figure 8).